Latest News

Leadartis presenting at the AseBio Investor Day 2020
17-09-2020

Leadartis will be presenting its business proposal at the AseBio Investor Day (...

LEADARTIS, THE LEADING IMMUNO-ONCOLOGY COMPANY IN SPAIN, OPENS A €1 MILLION ROUND TOGETHER WITH INVEREADY, SODENA AND CDTI INNVIERTE FOR THE DEVELOPMENT OF ITS FIRST PRODUCT IN ADVANCED CANCERS
11-09-2020

LEADARTIS, a company dedicated to the development of IMMUNO-ONCOLOGICAL medicines based on its...

Investigadores crean molécula eficaz ante el progreso de células tumorales
15-11-2018

LA VANGUARDIA

Madrid, 15 nov (EFE).- Un grupo de investigadores del Hospital 12 de...